Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated about 19 hours ago
ADA: Tolerability ‘not to be underappreciated’ in Roche, Zealand’s amylin obesity prospect
about 19 hours ago
As the American Diabetes Association 2026 Scientific Sessions kicked off in New...
ADA: Lilly pulls back curtain on impressive triple-G efficacy in patients with obesity, diabetes
1 day ago
Even as Zepbound fires on all cylinders and Foundayo gets off to...
ADA: Pfizer pads case for berobenatide in obesity, adding validation to Metsera buy
1 day ago
On the heels of a strong showing for the drug earlier this...
‘It looks like this hypothesis will pan out’: Cullinan unveils data building case for autoimmune TCEs
1 day ago
When it comes to turning T-cell therapies toward autoimmune diseases, CAR-Ts have...
Executive Interviews at Fierce Biotech Week 2026
2 days ago
Discover how these trailblazers are accelerating breakthroughs, forging impactful partnerships, and redefining...
Could engaging the immune system improve AML outcomes?
2 days ago
With unmet need still high in AML, new approaches are exploring whether...
How AI is reshaping biopharma decision-making
2 days ago
AI is accelerating discovery, but only when paired with expert insight and...
Affibody gets izokibep ‘back on track’ while seeking ‘new home’ after drug’s Acelyrin rejection
2 days ago
Affibody may not have expected to be working on izokibep again, but...
Insulet debuts latest enhancements to popular Omnipod insulin delivery system
2 days ago
Insulet, the diabetes device maker, debuted upgrades to its popular Omnipod 5...
Chutes & Ladders—AstraZeneca adds FDA cell and gene veteran
3 days ago
Longtime FDA leader Lola Fashoyin-Aje, M.D., is adapting to a new role...
How RA Capital is offering its biotechs ‘Chinese clinical expertise in a box’
3 days ago
Rather than leave the work of developing relationships in China to individual...
At first public hearing for FDA’s CNPV program, industry support meets ‘deep concern’ from experts
3 days ago
On Thursday, the public had the first chance to air their grievances...